Literature DB >> 7719906

Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection.

J J Christensen1, J Renneberg, B Bruun, A Forsgren.   

Abstract

We searched for antibodies against Moraxella (Branhamella) catarrhalis proteins in the sera of patients with lower respiratory tract infection. Sera from 48 patients with M. catarrhalis and 39 patients without M. catarrhalis in their lower respiratory tract specimens were studied by a gel electrophoresis-immunoperoxidase technique; sera from 23 healthy adult blood donors were also included. Immunoglobulin G (IgG) antibodies against a 28-kDa protein were found significantly more frequently in patients with M. catarrhalis in lower respiratory tract specimens (71%) than in patients without M. catarrhalis in lower respiratory tract specimens (28%) or healthy adult blood donors (22%). Seroconversion, from the acute to the convalescent stages, occurred in at least eight patients with M. catarrhalis and in one patient without detectable M. catarrhalis. IgG antibodies against other M. catarrhalis proteins were found in most sera, including those obtained from blood donors. By adsorption experiments the 28-kDa protein was demonstrated to be surface exposed. IgM antibodies against an 85-kDa protein were found in serum from one patient from whom M. catarrhalis and Streptococcus pneumoniae were isolated from the lower respiratory tract, while IgA antibodies against M. catarrhalis proteins could not be detected in any serum specimen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719906      PMCID: PMC170093          DOI: 10.1128/cdli.2.1.14-17.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  19 in total

1.  [Gonococcal complement fixation reaction in patients with lung diseases in Greenland].

Authors:  P K Lange; A Reyn; M W Bentzon; I Lind
Journal:  Ugeskr Laeger       Date:  1966-04-07

2.  Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains.

Authors:  T Nagatake
Journal:  Tohoku J Exp Med       Date:  1985-09       Impact factor: 1.848

3.  Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; B Weise; A M Van den Abeele
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.

Authors:  D T McLeod; F Ahmad; M J Croughan; M A Calder
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

6.  A protein antigen characteristic of Branhamella catarrhalis. Serological identification of the genus.

Authors:  I Eliasson
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-10

7.  Branhamella catarrhalis: significance in pulmonary infections and bacteriological features.

Authors:  J J Christensen; O Gadeberg; B Bruun
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1986-04

Review 8.  Branhamella catarrhalis respiratory infections.

Authors:  H Hager; A Verghese; S Alvarez; S L Berk
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec

9.  Neisseria meningitidis: occurrence in non-pneumonic pulmonary infections.

Authors:  J J Christensen; O Gadeberg; B Bruun
Journal:  APMIS       Date:  1988-03       Impact factor: 3.205

10.  Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections.

Authors:  A J Black; T S Wilson
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

View more
  6 in total

1.  Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.

Authors:  J J Christensen; N Q Hansen; B Bruun
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

2.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.

Authors:  Thuan Tong Tan; Jens Jørgen Christensen; Morten Hanefeld Dziegiel; Arne Forsgren; Kristian Riesbeck
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

4.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

Authors:  D Chen; J C McMichael; K R VanDerMeid; D Hahn; T Mininni; J Cowell; J Eldridge
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

6.  Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E.

Authors:  C Aebi; E R Lafontaine; L D Cope; J L Latimer; S L Lumbley; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.